STAT+: Five midterm races to watch that could be crucial for vaccine policy
GOP candidates in Iowa and Florida are embracing vaccine skepticism, while Democrats in Michigan and South Carolina are…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 728 articles · page 12 of 21 · fetched 15 minutes ago
STAT+: U.K. unveils recommendations for regulating AI in medicine
A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in…
Read at source →
Coroner releases details of infants who died amid growing Pennsylvania measles outbreak
The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop…
Read at source →
STAT+: Can AI fix the emergency room?
AI can't change the ER's problems, which exemplify health care's bigger problems, writes Brittany Trang in this week's…
Read at source →
STAT+: Orexin discoverers awarded prestigious Lasker award
A new FDA CBER head, AI company Schrodinger with a new startup, and more biotech news from The Readout
Read at source →
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials
Read at source →
Telemedicine company offers GLP-1s for addiction
A CDC Covid restructuring, public trust in Fauci, and more health news from Morning Rounds
Read at source →
STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
Caspian Therapeutics, is launching with $50 million in financing to develop menin inhibitors for diabetes and other…
Read at source →
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
“Autonomous AI will likely soon exceed both unaided physicians and physicians aided by AI at five core cognitive…
Read at source →
Opinion: AMA CEO: AI won’t replace doctors — it will work alongside them
“The goal should not be to reproduce today’s health care system with fewer humans,” writes American Medical Association…
Read at source →
STAT+: Can AI fix health care? In the chaos of emergency rooms, the technology comes up short
CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of…
Read at source →
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
The moves bring stability to an agency that's been rocked by the exits of top leadership.
Read at source →
STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed…
Read at source →
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
UnitedHealth execs shower a top Democrats with cash, and the No Surprises Act debate heats up.
Read at source →
STAT+: Health care features prominently in Democrats’ agenda
Democrats are sharpening their health care plans as the midterm elections near.
Read at source →
STAT+: Oura files to goes public, reported $1.2B in earnings
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more
Read at source →
STAT+: FDA approves AstraZeneca breast cancer drug
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more…
Read at source →STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study
Read at source →
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the…
Read at source →
An administrative gap delays access to new pancreatic cancer treatment
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
Read at source →
STAT+: Inhibrx claims first win for long-sought immunotherapy target
“Pushing this is like a rock up a hill, because there’s been so much failure in the space,” said Inhibrx CEO Mark Lappe.
Read at source →
STAT+: Roivant lung disease drug hits mid-stage study goals
These positive results could open up a new way to treat serious lung disease.
Read at source →
Reynolds is selling fruity new vapes unauthorized by FDA
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to…
Read at source →
A breakthrough pancreatic cancer drug won approval. They still struggle to access it
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping…
Read at source →
STAT+: UnitedHealth executives shower high-ranking Democrat with donations ahead of midterms
Katherine Clark, a top House Democrat, received more than $100,000 in campaign donations from people linked to…
Read at source →
Opinion: It’s time to take the gloves off during vaccination
Most of the time, it’s unnecessary to use gloves to administer a flu shot, write Cassandra Thiel and Preeti Jaggi.
Read at source →
Opinion: I’m a fat medical student. I refuse to let myself be shamed for it
“As a medical student in a larger body, I have often been ostracized, othered, made to feel different, like I’ve…
Read at source →
Hospitals pursue deals to ensure survival as Trump’s Medicaid cuts loom
Rural health systems are seeking partnership to survive, fueling a debate over competition and the rising cost of…
Read at source →
STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in…
Read at source →
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health,…
Read at source →
STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting
The American Diabetes Association “continues to move from crisis to crisis to crisis,” says one of five members ejected…
Read at source →
Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more
“A click, signature, or brief review should not magically transfer responsibility from an AI developer or platform to a…
Read at source →
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to…
Read at source →
STAT+: Top Boston hospitals clash over Medicare Advantage network after split
First, Mass General Brigham split with Dana-Farber. Now its Medicare Advantage plan is dropping the cancer hospital.
Read at source →
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think…
Read at source →